Capsid stabilization reprograms the nuclear fate of the HIV genome
Science Advances · 07.08.2026 · 12 (32)
DOI: 10.1126/sciadv.aef9469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 07.08.2026. Verfasst von Thierry Mourer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Virology Department, Institut Pasteur, Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: HIV-1, Capsid, Genome, Viral, Cell Nucleus. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Engineering and Physical Sciences Research Council, Agence Nationale de la Recherche, ANR/PRCI.
Abstract (Originalsprache)
Capsid stabilization, induced by low-nanomolar concentrations of Lenacapavir (LEN)—a first-in-class capsid inhibitor—impedes HIV-1 replication in macrophages without disrupting reverse transcription or nuclear import. In LEN-treated cells, ultrastructural analyses reveal preserved conical capsids persisting within nuclear CPSF6-enriched puncta—HIV-1–induced membraneless organelles (HIV-1–MLOs)—which remain spatially segregated from canonical integration hubs near nuclear speckles (NSs). Rather than fusing with NSs, HIV-1–MLOs are rerouted to chromatin-associated promyelocytic leukemia nuclear bodies (PML-NBs), where molecular exchange occurs without condensate fusion. This nuclear redirection correlates with the sequestration of the viral genome within stabilized capsids, reducing the pool of viral DNA available for integration and redirecting the few accessible genomes to atypical integration sites near PML-NBs. These findings uncover a previously unrecognized mechanism of LEN action, whereby capsid stabilization reprograms the nuclear fate of the HIV-1 genome in macrophages, limiting integration and redirecting viral DNA toward more repressive nuclear environments, likely shaping the transcriptional potential of newly integrated viral DNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Virology Department, Institut Pasteur, Université Paris Cité, Paris, France.
- Image Analysis Hub (IAH), Institut Pasteur, Université Paris Cité, Paris, France.
- Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
- NanoImaging Core Facility (NCF), Institut Pasteur, Université Paris Cité, Paris, France.
- Genethon, Evry, France.
- Université Paris-Saclay, University of Evry, Inserm, Généthon, Integrare Research Unit UMR_S951, Evry-Courcouronnes, France.
ORCID-Profile: Thierry Mourer, Mohamad Harastani, Jose Ignacio Perez-Lopez, Stephane Tachon, Guillaume Corre, Maria Julia Maristany, Jean-Yves Tinevez, Anastasia Gazi, Valentina Poletti, Rosana Collepardo-Guevara, Anna Sartori-Rupp, Francesca Di Nunzio
Förderung
- Engineering and Physical Sciences Research Council
- Agence Nationale de la Recherche
- ANR/PRCI
- Institut Carnot/PTR
- Agence Nationale de Recherches sur le Sida et les Hepatites Virales
- EPSRC
- UKRI-EPSRC
- ERC
Zitieren
APA
Mourer, T., Harastani, M., Cuche, C., Perez-Lopez, J. I., Tornambe, S., Tachon, S., Corre, G., Maristany, M. J., Tinevez, J. Y., Gazi, A., Poletti, V., Collepardo-Guevara, R., Sartori-Rupp, A., & Di Nunzio, F. (2026). Capsid stabilization reprograms the nuclear fate of the HIV genome. Science Advances, 12(32). https://doi.org/10.1126/sciadv.aef9469
Vancouver
Mourer T, Harastani M, Cuche C, Perez-Lopez JI, Tornambe S, Tachon S, et al. Capsid stabilization reprograms the nuclear fate of the HIV genome. Science Advances. 2026;12(32). doi:10.1126/sciadv.aef9469
BibTeX
@article{Mourer2026,
author = {Mourer, Thierry and Harastani, Mohamad and Cuche, Celine and Perez-Lopez, Jose Ignacio and Tornambe, Salvatore and Tachon, Stephane and Corre, Guillaume and Maristany, Maria Julia and Tinevez, Jean-Yves and Gazi, Anastasia and Poletti, Valentina and Collepardo-Guevara, Rosana and Sartori-Rupp, Anna and Di Nunzio, Francesca},
title = {Capsid stabilization reprograms the nuclear fate of the HIV genome},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {32},
doi = {10.1126/sciadv.aef9469}
}
EUVIMED